113 related articles for article (PubMed ID: 25992553)
1. Minor Type IV Collagen α5 Chain Promotes Cancer Progression through Discoidin Domain Receptor-1.
Xiao Q; Jiang Y; Liu Q; Yue J; Liu C; Zhao X; Qiao Y; Ji H; Chen J; Ge G
PLoS Genet; 2015 May; 11(5):e1005249. PubMed ID: 25992553
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of t-DARPP Expression Alteration in Association with DDR1 Expression in Non-Small Cell Lung Cancer.
Damavandi Z; Riahi P; Majidizadeh T; Houshmand M
Iran Biomed J; 2024 Jan; 28(1):23-30. PubMed ID: 38308500
[TBL] [Abstract][Full Text] [Related]
3. The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus.
Chiusa M; Hu W; Liao HJ; Su Y; Borza CM; de Caestecker MP; Skrypnyk NI; Fogo AB; Pedchenko V; Li X; Zhang MZ; Hudson BG; Basak T; Vanacore RM; Zent R; Pozzi A
J Am Soc Nephrol; 2019 Sep; 30(9):1605-1624. PubMed ID: 31383731
[TBL] [Abstract][Full Text] [Related]
4. Type IV collagen drives alveolar epithelial-endothelial association and the morphogenetic movements of septation.
Loscertales M; Nicolaou F; Jeanne M; Longoni M; Gould DB; Sun Y; Maalouf FI; Nagy N; Donahoe PK
BMC Biol; 2016 Jul; 14():59. PubMed ID: 27412481
[TBL] [Abstract][Full Text] [Related]
5. Multifaceted collagen-DDR1 signaling in cancer.
Su H; Karin M
Trends Cell Biol; 2024 May; 34(5):406-415. PubMed ID: 37709651
[TBL] [Abstract][Full Text] [Related]
6. Identification of type IV collagen exposure as a molecular imaging target for early detection of thoracic aortic dissection.
Xu K; Xu C; Zhang Y; Qi F; Yu B; Li P; Jia L; Li Y; Xu FJ; Du J
Theranostics; 2018; 8(2):437-449. PubMed ID: 29290819
[TBL] [Abstract][Full Text] [Related]
7. A temporally-restricted pattern of endothelial cell collagen 4 alpha 1 expression during embryonic development determined with a novel knockin Col4a1-P2A-eGFP mouse line.
Lartey NL; van der Ent M; Alonzo R; Chen D; King PD
Genesis; 2024 Feb; 62(1):e23539. PubMed ID: 37501352
[TBL] [Abstract][Full Text] [Related]
8. Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.
Murray CW; Berdini V; Buck IM; Carr ME; Cleasby A; Coyle JE; Curry JE; Day JE; Day PJ; Hearn K; Iqbal A; Lee LY; Martins V; Mortenson PN; Munck JM; Page LW; Patel S; Roomans S; Smith K; Tamanini E; Saxty G
ACS Med Chem Lett; 2015 Jul; 6(7):798-803. PubMed ID: 26191369
[TBL] [Abstract][Full Text] [Related]
9. Discoidin domain receptor-1 as a player in impairment of melanocytes adhesion process in vitiligo.
Elgarhy LH; Abdullatif A; Abdelazim R; El-Desouky KI
G Ital Dermatol Venereol; 2016 Oct; 151(5):473-9. PubMed ID: 26091274
[TBL] [Abstract][Full Text] [Related]
10. Identification of miR-199a-5p target genes in the skin keratinocyte and their expression in cutaneous squamous cell carcinoma.
Kim BK; Kim I; Yoon SK
J Dermatol Sci; 2015 Aug; 79(2):137-47. PubMed ID: 26026896
[TBL] [Abstract][Full Text] [Related]
11. The Regulation of Matrix Metalloproteinase Expression and the Role of Discoidin Domain Receptor 1/2 Signalling in Zoledronate-treated PC3 Cells.
Reel B; Korkmaz CG; Arun MZ; Yildirim G; Ogut D; Kaymak A; Micili SC; Ergur BU
J Cancer; 2015; 6(10):1020-9. PubMed ID: 26366216
[TBL] [Abstract][Full Text] [Related]
12. High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma.
Huo Y; Yang M; Liu W; Yang J; Fu X; Liu D; Li J; Zhang J; Hua R; Sun Y
J Exp Clin Cancer Res; 2015 Aug; 34(1):88. PubMed ID: 26297342
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of discoidin domain receptor 2-mediated lung cancer cells progression by gold nanoparticle-aptamer-assisted delivery of peptides containing transmembrane-juxtamembrane 1/2 domain.
Kim D; Yeom JH; Lee B; Lee K; Bae J; Rhee S
Biochem Biophys Res Commun; 2015 Aug; 464(2):392-5. PubMed ID: 26067556
[TBL] [Abstract][Full Text] [Related]
14. Aggressive change of a carotid-cavernous fistula in a patient with Ehlers-Danlos syndrome type IV.
Kojima A; Saga I; Tomio R; Kosho T; Hatamochi A
Interv Neuroradiol; 2015 Jun; 21(3):341-5. PubMed ID: 26015525
[TBL] [Abstract][Full Text] [Related]
15. The discoidin domain receptor tyrosine kinases are activated by collagen.
Vogel W; Gish GD; Alves F; Pawson T
Mol Cell; 1997 Dec; 1(1):13-23. PubMed ID: 9659899
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell-specific collagen type IV-α
Funk SD; Bayer RH; Miner JH
Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
[TBL] [Abstract][Full Text] [Related]
17. Alport Syndrome: Achieving Early Diagnosis and Treatment.
Kashtan CE
Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
[TBL] [Abstract][Full Text] [Related]
18. Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5.
Yamamura T; Horinouchi T; Adachi T; Terakawa M; Takaoka Y; Omachi K; Takasato M; Takaishi K; Shoji T; Onishi Y; Kanazawa Y; Koizumi M; Tomono Y; Sugano A; Shono A; Minamikawa S; Nagano C; Sakakibara N; Ishiko S; Aoto Y; Kamura M; Harita Y; Miura K; Kanda S; Morisada N; Rossanti R; Ye MJ; Nozu Y; Matsuo M; Kai H; Iijima K; Nozu K
Nat Commun; 2020 Jun; 11(1):2777. PubMed ID: 32488001
[TBL] [Abstract][Full Text] [Related]
19. Modification of an aggressive model of Alport Syndrome reveals early differences in disease pathogenesis due to genetic background.
Falcone S; Wisby L; Nicol T; Blease A; Starbuck B; Parker A; Sanderson J; Brown SDM; Scudamore CL; Pusey CD; Tam FWK; Potter PK
Sci Rep; 2019 Dec; 9(1):20398. PubMed ID: 31892712
[TBL] [Abstract][Full Text] [Related]
20. Complexity of type IV collagens: from network assembly to function.
Wu Y; Ge G
Biol Chem; 2019 Apr; 400(5):565-574. PubMed ID: 30864416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
